Skip to main content
NCD 240.4.1 · version 1

NCD 240.4.1: Sleep Testing for Obstructive Sleep Apnea (OSA)

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 240.4.1

Benefit category
Diagnostic Tests (other)
Effective date
03/03/2009
Implemented 08/10/2009
Transmittal
Transmittal 103
Versions published
1
Manual section
240
Respiratory System, NCD Manual (Pub. 100-03) chapter 1 part 4

TL;DR

NCD 240.4.1 sets Medicare's national policy for sleep testing for obstructive sleep apnea (osa) under the benefit category "Diagnostic Tests (other)", effective 03/03/2009 and implemented 08/10/2009. Effective for claims with dates of service on and after March 3, 2009, the Centers for Medicare & Medicaid Services finds that the evidence is sufficient to determine that the results of the sleep tests identified below can be used by a beneficiary’s treating… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Item or service described

A. General

Obstructive sleep apnea (OSA) is the collapse of the oropharyngeal walls and the obstruction of airflow occurring during sleep. Diagnostic tests for OSA have historically been classified into four types. The most comprehensive is designated Type I attended facility based polysomnography (PSG), which is considered the reference standard for diagnosing OSA. Attended facility based polysomnogram is a comprehensive diagnostic sleep test including at least electroencephalography (EEG), electro-oculography (EOG), electromyography (EMG), heart rate or electrocardiography (ECG), airflow, breathing/respiratory effort, and arterial oxygen saturation (SaO 2 ) furnished in a sleep laboratory facility in which a technologist supervises the recording during sleep time and has the ability to intervene if needed. Overnight PSG is the conventional diagnostic test for OSA. The American Thoracic Society and the American Academy of Sleep Medicine have recommended supervised PSG in the sleep laboratory over 2 nights for the diagnosis of OSA and the initiation of continuous positive airway pressure (CPAP).

Three categories of portable monitors (used both in attended and unattended settings) have been developed for the diagnosis of OSA. Type II monitors have a minimum of 7 channels (e.g., EEG, EOG, EMG, ECG-heart rate, airflow, breathing/respiratory effort, SaO 2 )-this type of device monitors sleep staging, so AHI can be calculated). Type III monitors have a minimum of 4 monitored channels including ventilation or airflow (at least two channels of respiratory movement or respiratory movement and airflow), heart rate or ECG, and oxygen saturation. Type IV devices may measure one, two, three or more parameters but do not meet all the criteria of a higher category device. Some monitors use an actigraphy algorithm to identify periods of sleep and wakefulness.

Indications and limitations of coverage

B. Nationally Covered Indications

Effective for claims with dates of service on and after March 3, 2009, the Centers for Medicare & Medicaid Services finds that the evidence is sufficient to determine that the results of the sleep tests identified below can be used by a beneficiary’s treating physician to diagnose OSA, that the use of such sleep testing technologies demonstrates improved health outcomes in Medicare beneficiaries who have OSA and receive the appropriate treatment, and that these tests are thus reasonable and necessary under section 1862(a)(1)(A) of the Social Security Act.

1. Type I PSG is covered when used to aid the diagnosis of OSA in beneficiaries who have clinical signs and symptoms indicative of OSA if performed attended in a sleep lab facility.

2. Type II or Type III sleep testing devices are covered when used to aid the diagnosis of OSA in beneficiaries who have clinical signs and symptoms indicative of OSA if performed unattended in or out of a sleep lab facility or attended in a sleep lab facility.

3. Type IV sleep testing devices measuring three or more channels, one of which is airflow, are covered when used to aid the diagnosis of OSA in beneficiaries who have signs and symptoms indicative of OSA if performed unattended in or out of a sleep lab facility or attended in a sleep lab facility.

4. Sleep testing devices measuring three or more channels that include actigraphy, oximetry, and peripheral arterial tone, are covered when used to aid the diagnosis of OSA in beneficiaries who have signs and symptoms indicative of OSA if performed unattended in or out of a sleep lab facility or attended in a sleep lab facility.

C. Nationally Non-Covered Indications

Effective for claims with dates of services on and after March 3, 2009, other diagnostic sleep tests for the diagnosis of OSA, other than those noted above for prescribing CPAP, are not sufficient for the coverage of CPAP and are not covered.

D. Other

N/A

(This NCD last reviewed March 2009.)

Text reproduced from the CMS Medicare Coverage Database record for NCD 240.4.1 version 1. View the original on cms.gov.

Local policies that build on this NCD

12 active Local Coverage Determinations cite NCD 240.4.1 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 240.4.1

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 8 current articles in the Medicare Coverage Database name NCD 240.4.1, 8 of them with a covered ICD-10-CM list, from 7 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

A52467: Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea - Policy Article

Article, effective 2021-08-08 · CGS Administrators, LLC (17013, 18003); Noridian Healthcare Solutions, LLC (16013, 19003) · CMS record

1 covered ICD-10-CM code. Local policy: L33718 Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea.

First covered codes: G47.33 Obstructive sleep apnea (adult) (pediatric).

A56923: Billing and Coding: Outpatient Sleep Studies

Billing and Coding, effective 2023-01-01 · Novitas Solutions, Inc. (04111, 04112, 04211, 04212, 04311, 04312, 04411, 04412, 04911, 07101, 07102, 07201, 07202, 07301, 07302, 12101, 12102, 12201, 12202, 12301, 12302, 12401, 12402, 12501, 12502, 12901) · CMS record

83 covered ICD-10-CM codes in 2 groups; 14 procedure codes: 95782, 95783, 95800, 95801, 95805, 95806, 95807, 95808, 95810, 95811, 95999, G0398 and 2 more. Local policy: L35050 Outpatient Sleep Studies. Check a diagnosis for 95782.

First covered codes: E66.2 Morbid (severe) obesity with alveolar hypoventilation; F11.182 Opioid abuse with opioid-induced sleep disorder; F11.282 Opioid dependence with opioid-induced sleep disorder; F11.982 Opioid use, unspecified with opioid-induced sleep disorder; F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder; F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder; …

A56995: Billing and Coding: Polysomnography

Billing and Coding, effective 2024-03-07 · Palmetto GBA (10111, 10112, 10211, 10212, 10311, 10312, 11201, 11202, 11301, 11302, 11401, 11402, 11501, 11502) · CMS record

28 covered ICD-10-CM codes in 4 groups; 14 procedure codes: 95782, 95783, 95800, 95801, 95803, 95805, 95806, 95807, 95808, 95810, 95811, G0398 and 2 more. Local policy: L36593 Polysomnography. Check a diagnosis for 95782.

First covered codes: F51.3 Sleepwalking [somnambulism]; F51.4 Sleep terrors [night terrors]; F51.5 Nightmare disorder; G47.10 Hypersomnia, unspecified; G47.11 Idiopathic hypersomnia with long sleep time; G47.12 Idiopathic hypersomnia without long sleep time; …

A57049: Billing and Coding: Polysomnography and Other Sleep Studies

Billing and Coding, effective 2026-03-05 · CGS Administrators, LLC (15101, 15102, 15201, 15202) · CMS record

24 covered ICD-10-CM codes in 4 groups; 14 procedure codes: 95782, 95783, 95800, 95801, 95803, 95805, 95806, 95807, 95808, 95810, 95811, G0398 and 2 more. Local policy: L36902 Polysomnography and Other Sleep Studies. Check a diagnosis for 95782.

First covered codes: G47.10 Hypersomnia, unspecified; G47.13 Recurrent hypersomnia; G47.14 Hypersomnia due to medical condition; G47.19 Other hypersomnia; G47.30 Sleep apnea, unspecified; G47.411 Narcolepsy with cataplexy; …

A57092: Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea

Billing and Coding, effective 2026-10-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

18 covered ICD-10-CM codes in 2 groups; 3 procedure codes: 64582, 64583, 64584. Local policy: L38387 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea. Check a diagnosis for 64582.

First covered codes: G47.33 Obstructive sleep apnea (adult) (pediatric); Z68.18 Body mass index [BMI] 18.4 or less, adult; Z68.19 Body mass index [BMI] 18.5-19.9, adult; Z68.20 Body mass index [BMI] 20.0-20.9, adult; Z68.21 Body mass index [BMI] 21.0-21.9, adult; Z68.22 Body mass index [BMI] 22.0-22.9, adult; …

A57496: Billing and Coding: Polysomnography and Sleep Testing

Billing and Coding, effective 2024-05-16 · First Coast Service Options, Inc. (09101, 09102, 09201, 09202, 09302) · CMS record

28 covered ICD-10-CM codes in 4 groups; 13 procedure codes: 95782, 95783, 95800, 95801, 95805, 95806, 95807, 95808, 95810, 95811, G0398, G0399 and 1 more. Local policy: L33405 Polysomnography and Sleep Testing. Check a diagnosis for 95782.

First covered codes: F51.3 Sleepwalking [somnambulism]; F51.4 Sleep terrors [night terrors]; F51.5 Nightmare disorder; F51.8 Other sleep disorders not due to a substance or known physiological condition; G47.10 Hypersomnia, unspecified; G47.11 Idiopathic hypersomnia with long sleep time; …

A57697: Billing and Coding: Polysomnography and Other Sleep Studies

Billing and Coding, effective 2025-09-11 · Noridian Healthcare Solutions, LLC (01111, 01112, 01182, 01211, 01212, 01311, 01312, 01911, 02101, 02102, 02201, 02202, 02301, 02302, 02401, 02402, 03101, 03102, 03201, 03202, 03301, 03302, 03401, 03402, 03501, 03502, 03601, 03602) · CMS record

26 covered ICD-10-CM codes in 4 groups; 14 procedure codes: 95782, 95783, 95800, 95801, 95803, 95805, 95806, 95807, 95808, 95810, 95811, G0398 and 2 more. Local policy: L36861 Polysomnography and Other Sleep Studies. Check a diagnosis for 95782.

First covered codes: G47.10 Hypersomnia, unspecified; G47.13 Recurrent hypersomnia; G47.14 Hypersomnia due to medical condition; G47.19 Other hypersomnia; G47.30 Sleep apnea, unspecified; G47.411 Narcolepsy with cataplexy; …

A57944: Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea

Billing and Coding, effective 2026-10-01 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record

18 covered ICD-10-CM codes in 2 groups; 6 procedure codes: 64582, 64583, 64584, C8007, C8008, C8009. Local policy: L35490 Category III Codes, L38528 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea. Check a diagnosis for 64582.

First covered codes: G47.33 Obstructive sleep apnea (adult) (pediatric); Z68.18 Body mass index [BMI] 18.4 or less, adult; Z68.19 Body mass index [BMI] 18.5-19.9, adult; Z68.20 Body mass index [BMI] 20.0-20.9, adult; Z68.21 Body mass index [BMI] 21.0-21.9, adult; Z68.22 Body mass index [BMI] 22.0-22.9, adult; …

Coverage analysis history

CMS opens a national coverage analysis (NCA) to create or reconsider an NCD; the analysis carries a CAG tracking number, the evidence review and the decision memo. The Medicare Coverage Database links one analysis to NCD 240.4.1, listed here in the order CMS opened them (by NCA record number). A reconsideration ("Recon") revisits an earlier decision; an analysis whose status is open is still in progress.

  1. CAG-00405N Sleep Testing for Obstructive Sleep Apnea (OSA) (New, Closed)

Revision history

07/2009 - Previously, although CPAP was nationally covered for beneficiaries with OSA if diagnosed with specific tests, coverage of the tests themselves was left to local contractor discretion. As a result of this recent NCD, effective for claims with dates of service on and after March 3, 2009, Medicare will allow for coverage of the sleep testing devices, specifically: Type 1 PSG when the test is attended in a sleep lab facility, Type II or Type III if performed unattended in or out of a sleep lab facility or attended in a sleep lab facility, or Type IV measuring 3 or more channels, one of which is airflow, if performed unattended in or out of a sleep lab facility or attended in a sleep lab facility. Effective Date: 03/03/2009 Implementation Date: 08/10/2009 ( TN 103 ) (CR6534)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 240.4.1

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 240.4.1

What does NCD 240.4.1 cover?

Effective for claims with dates of service on and after March 3, 2009, the Centers for Medicare & Medicaid Services finds that the evidence is sufficient to determine that the results of the sleep tests identified below can be used by a beneficiary’s treating physician to diagnose OSA, that the use of such sleep testing technologies demonstrates improved health outcomes in Medicare beneficiaries who have OSA… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 240.4.1 take effect?

The current version (1) is effective 03/03/2009, implemented 08/10/2009, published in transmittal 103. This is the only published version.

Does a Local Coverage Determination override NCD 240.4.1?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.